Cargando…

Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study

Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobert, Markus A., Nussbaum, Susanne, Heger, Tanja, Berg, Daniela, Maetzler, Walter, Heinzel, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381067/
https://www.ncbi.nlm.nih.gov/pubmed/30814947
http://dx.doi.org/10.3389/fnagi.2019.00022
_version_ 1783396411674460160
author Hobert, Markus A.
Nussbaum, Susanne
Heger, Tanja
Berg, Daniela
Maetzler, Walter
Heinzel, Sebastian
author_facet Hobert, Markus A.
Nussbaum, Susanne
Heger, Tanja
Berg, Daniela
Maetzler, Walter
Heinzel, Sebastian
author_sort Hobert, Markus A.
collection PubMed
description Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait parameters from a lower-back sensor under convenient and challenging walking conditions in early- and mid-stage PD patients (E-PD, M-PD) compared to controls were investigated. Methods: Normal- and fast-pace parameters (step: number, time, velocity, variability) were assessed every 6 months for up to 5 years in 22 E-PD (<4 years baseline disease duration), 18 M-PD (>5 years) and 24 controls. Parameter trajectories and associations with MDS-UPDRS-III were tested using generalized estimating equations. Results: Normal-pace step number (annual change in E-PD: 2.1%, Time(∗)Group: p = 0.001) and step time variability (8.5%, p < 0.05) longitudinally increased in E-PD compared to controls (0.7%, -12%). For fast pace, no significant progression differences between groups were observed. Longitudinal changes in M-PD did not differ significantly from controls. MDS-UPDRS-III was largely associated with normal-pace parameters in M-PD. Conclusion: Wearables can quantify progressive gait deficits indicated by increasing step number and step time variability in E-PD. In M-PD, and for fast-pace, gait parameters possess limited potential as PD progression markers.
format Online
Article
Text
id pubmed-6381067
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63810672019-02-27 Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study Hobert, Markus A. Nussbaum, Susanne Heger, Tanja Berg, Daniela Maetzler, Walter Heinzel, Sebastian Front Aging Neurosci Neuroscience Background: Gait changes occur during all Parkinson’s disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Objectives: Longitudinal changes in gait parameters from a lower-back sensor under convenient and challenging walking conditions in early- and mid-stage PD patients (E-PD, M-PD) compared to controls were investigated. Methods: Normal- and fast-pace parameters (step: number, time, velocity, variability) were assessed every 6 months for up to 5 years in 22 E-PD (<4 years baseline disease duration), 18 M-PD (>5 years) and 24 controls. Parameter trajectories and associations with MDS-UPDRS-III were tested using generalized estimating equations. Results: Normal-pace step number (annual change in E-PD: 2.1%, Time(∗)Group: p = 0.001) and step time variability (8.5%, p < 0.05) longitudinally increased in E-PD compared to controls (0.7%, -12%). For fast pace, no significant progression differences between groups were observed. Longitudinal changes in M-PD did not differ significantly from controls. MDS-UPDRS-III was largely associated with normal-pace parameters in M-PD. Conclusion: Wearables can quantify progressive gait deficits indicated by increasing step number and step time variability in E-PD. In M-PD, and for fast-pace, gait parameters possess limited potential as PD progression markers. Frontiers Media S.A. 2019-02-13 /pmc/articles/PMC6381067/ /pubmed/30814947 http://dx.doi.org/10.3389/fnagi.2019.00022 Text en Copyright © 2019 Hobert, Nussbaum, Heger, Berg, Maetzler and Heinzel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Hobert, Markus A.
Nussbaum, Susanne
Heger, Tanja
Berg, Daniela
Maetzler, Walter
Heinzel, Sebastian
Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title_full Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title_fullStr Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title_full_unstemmed Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title_short Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
title_sort progressive gait deficits in parkinson’s disease: a wearable-based biannual 5-year prospective study
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381067/
https://www.ncbi.nlm.nih.gov/pubmed/30814947
http://dx.doi.org/10.3389/fnagi.2019.00022
work_keys_str_mv AT hobertmarkusa progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy
AT nussbaumsusanne progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy
AT hegertanja progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy
AT bergdaniela progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy
AT maetzlerwalter progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy
AT heinzelsebastian progressivegaitdeficitsinparkinsonsdiseaseawearablebasedbiannual5yearprospectivestudy